Antioxidant efficacy of a Spirulina water extract (Spirulysat) on oxidised LDL status and lipid metabolism in metabolic syndrome
Metabolic Syndrome
Enrolment: 40 · Results not recorded
Loading the evidence…
Nutraceutical · Crude cyanobacterial (Arthrospira platensis) preparation; no ChEMBL entity.
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Metabolic Syndrome
Enrolment: 40 · Results not recorded
HBV Carrier
Enrolment: 72 · Results not recorded
Metabolic Syndrome
Enrolment: 30 · Results not recorded
Obesity
Enrolment: 52 · Results not recorded
Obesity
Enrolment: 35 · Results not recorded
Stunting · Underweight · Malaria · Motor Delay
Enrolment: 501 · Results not recorded
Insomnia Disorder
Enrolment: 180 · Results not recorded
Dyspepsia
Enrolment: 30 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Acute hepatotoxicity induced by a single intraperitoneal injection of D-galactosamine at 300 mg/kg body weight, with food withheld for four hours before and after dosing
D-galactosamine caused fatty degeneration, necrosis, apoptosis and perivascular inflammation, raised TNF-alpha, IL-1beta, IL-6 and TBARS, and lowered total protein and antioxidant enzyme activity. Dietary Spirulina gave dose-dependent protection, with 6% and 9% diets restoring near-normal hepatocyt…
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.